Uroviva is a Swiss-based startup specializing in urology with a network of ten urological practices, a specialized urology clinic, and an andrology center in the Zurich to Sursee Luzern area. Established in 2004, the company prides itself on a team of 32 specialists who provide comprehensive outpatient and inpatient urological care. Uroviva's focus lies in preventive care, evaluation, and treatment of male genital organ disorders, urogenital system issues, and urinary tract organs for both men and women. The company's ethos revolves around merging medical expertise, superior treatment quality, and compassionate patient care, prioritizing ample time for each patient's needs. Although specific investment details and investors are undisclosed, Uroviva presents an intriguing opportunity in the healthcare industry, particularly in the urology sector, for potential venture capital investments.
There is no investment information
No recent news or press coverage available for Uroviva.